Coronavirus (COVID-19) Resource Center

Professionals

Name	Title	Office	Email
Chris Bator Cleveland +1.216.861.7372 Counsel Chris Bator	Counsel	Cleveland	cbator@bakerlaw.com
Edward J. Bernert Columbus +1.614.462.2687 Partner Edward J. Bernert	Partner	Columbus	ebernert@bakerlaw.com
Daniel J. Buzzetta New York +1.212.589.4236 Partner Daniel J. Buzzetta	Partner	New York	dbuzzetta@bakerlaw.com
Phillip M. Callesen Cleveland +1.216.861.7884 Partner Phillip M. Callesen	Partner	Cleveland	pcallesen@bakerlaw.com
Christopher J. Carolan New York +1.212.589.4658 Partner Christopher J. Carolan	Partner	New York	ccarolan@bakerlaw.com
Joseph L. Chairez Costa Mesa +1.714.966.8822 Partner Joseph L. Chairez	Partner	Costa Mesa	jchairez@bakerlaw.com
Mark A. Cymrot Washington, D.C. +1.202.861.1677 Partner Mark A. Cymrot	Partner	Washington, D.C.	mcymrot@bakerlaw.com
Sashe D. Dimitroff Houston +1.713.646.1320 Partner Sashe D. Dimitroff	Partner	Houston	sdimitroff@bakerlaw.com
Michael A. Ferguson Washington, D.C. +1.202.861.1663 Senior Advisor Michael A. Ferguson	Senior Advisor	Washington, D.C.	mferguson@bakerlaw.com
David M. Friebus Chicago +1.312.416.6234 Partner David M. Friebus	Partner	Chicago	dfriebus@bakerlaw.com
Lisa M. Ghannoum Cleveland +1.216.861.7872 Partner Lisa M. Ghannoum	Partner	Cleveland	lghannoum@bakerlaw.com
John M. Gherlein Cleveland +1.216.861.7398 Partner John M. Gherlein	Partner	Cleveland	jgherlein@bakerlaw.com
May Tal Gongolevsky New York +1.212.589.4213 Partner May Tal Gongolevsky	Partner	New York	mgongolevsky@bakerlaw.com
Elizabeth A. Green Orlando +1.407.649.4036 Partner Elizabeth A. Green	Partner	Orlando	egreen@bakerlaw.com
Kurt P. Gruber Orlando +1.407.649.4042 Partner Kurt P. Gruber	Partner	Orlando	kgruber@bakerlaw.com
Seth J. Hanft Columbus +1.614.462.4778 Counsel Seth J. Hanft	Counsel	Columbus	shanft@bakerlaw.com
Michelle M. Hervey Cleveland +1.216.861.7290 Partner Michelle M. Hervey	Partner	Cleveland	mhervey@bakerlaw.com
Susan Whittaker Hughes Cleveland +1.216.861.7841 Partner Susan Whittaker Hughes	Partner	Cleveland	shughes@bakerlaw.com
Nancy Inesta Los Angeles +1.310.442.8833 Partner Nancy Inesta	Partner	Los Angeles	ninesta@bakerlaw.com
Edward J. Jacobs New York +1.212.589.4674 Partner Edward J. Jacobs	Partner	New York	ejacobs@bakerlaw.com
Christian B. Jones Washington, D.C. +1.202.861.1617 Senior Advisor Christian B. Jones	Senior Advisor	Washington, D.C.	cjones@bakerlaw.com
Mark A. Kadzielski Los Angeles +1.310.442.8815 Partner Mark A. Kadzielski	Partner	Los Angeles	mkadzielski@bakerlaw.com
Gilbert S. Keteltas Washington, D.C. +1.202.861.1530 Partner Gilbert S. Keteltas	Partner	Washington, D.C.	gketeltas@bakerlaw.com
Jay P. Krupin Washington, D.C. +1.202.861.1700 Partner Jay P. Krupin	Partner	Washington, D.C.	jkrupin@bakerlaw.com
L. Poe Leggette Houston / Denver +1.713.276.1647 / +1.303.764.4020 Partner L. Poe Leggette	Partner	Houston	pleggette@bakerlaw.com
John R. Lehrer II Washington, D.C. +1.202.861.1620 Partner John R. Lehrer II	Partner	Washington, D.C.	jlehrer@bakerlaw.com
Charlene L. McGinty Atlanta +1.404.256.8232 Partner Charlene L. McGinty	Partner	Atlanta	cmcginty@bakerlaw.com
John Melicharek Jr. Orlando / New York +1.407.649.4086 / +1.212.589.4284 Partner John Melicharek Jr.	Partner	Orlando	jmelicharek@bakerlaw.com
Jennifer A. Mills Cleveland +1.216.861.7874 Partner Jennifer A. Mills	Partner	Cleveland	jmills@bakerlaw.com
William Oxley Los Angeles +1.310.442.8894 Partner William Oxley	Partner	Los Angeles	woxley@bakerlaw.com
Jeffrey H. Paravano Washington, D.C. +1.202.861.1770 Partner Jeffrey H. Paravano	Partner	Washington, D.C.	jparavano@bakerlaw.com
Laurin D. Quiat Denver +1.303.764.4136 Partner Laurin D. Quiat	Partner	Denver	lquiat@bakerlaw.com
Kenneth B. Reisenfeld Washington, D.C. +1.202.861.1545 Partner Kenneth B. Reisenfeld	Partner	Washington, D.C.	kreisenfeld@bakerlaw.com
Jorian L. Rose New York +1.212.589.4681 Partner Jorian L. Rose	Partner	New York	jrose@bakerlaw.com
Lee H. Rosebush Washington, D.C. +1.202.861.1567 Partner Lee H. Rosebush	Partner	Washington, D.C.	lrosebush@bakerlaw.com
Nathan A. Schacht Denver +1.303.764.4029 Counsel Nathan A. Schacht	Counsel	Denver	nschacht@bakerlaw.com
Michael J. Semes Philadelphia +1.215.564.8270 Of Counsel Michael J. Semes	Of Counsel	Philadelphia	msemes@bakerlaw.com
Lynn Sessions Houston +1.713.646.1352 Partner Lynn Sessions	Partner	Houston	lsessions@bakerlaw.com
Lance L. Shea M.S., J.D. Washington, D.C. +1.202.861.1648 Partner Lance L. Shea M.S., J.D.	Partner	Washington, D.C.	lshea@bakerlaw.com
James A. Sherer New York +1.212.589.4279 Partner James A. Sherer	Partner	New York	jsherer@bakerlaw.com
Janet A. Spreen Cleveland +1.216.861.7564 Partner Janet A. Spreen	Partner	Cleveland	jspreen@bakerlaw.com
Trevor M. Stanley Washington, D.C. +1.202.861.1551 Partner Trevor M. Stanley	Partner	Washington, D.C.	tstanley@bakerlaw.com
Todd J. Thorson Dallas +1.214.210.1222 Partner Todd J. Thorson	Partner	Dallas	tthorson@bakerlaw.com
Amy J. Traub New York +1.212.589.4248 Partner Amy J. Traub	Partner	New York	atraub@bakerlaw.com
W. Ray Whitman Houston / Dallas +1.713.646.1367 / +1.214.210.1200 Partner W. Ray Whitman	Partner	Houston	rwhitman@bakerlaw.com

News

News

• 7/8/2020
  Sabrina Shadi Featured in Article Discussing Employment Issues During Pandemic
• 6/2/2020
  Brian Davis, Michael Semes Lead Webinar on Tax Issues in COVID-19 Era
• 6/2/2020
  John Carney, Jimmy Fokas Speak on "Accounting for Lawyers" Webinar
• 5/21/2020
  Mark Kadzielski a Speaker for Webinar on COVID-19 Challenges Facing Healthcare Facilities
• 5/19/2020
  Ann O'Brien Speaks on Webinar Regarding Price Gouging During the COVID-19 Crisis
• 5/18/2020
  Jeff Paravano Comments on New Guidance for PPP Loan Forgiveness
• 5/15/2020
  Susrut Carpenter a Speaker for Punjabi Chamber of Commerce Webinar on COVID-19 Impact
• 5/13/2020
  Ann O'Brien Discusses Price Gouging During COVID-19 on Webinar
• 5/11/2020
  BakerHostetler Orlando Partners Elizabeth Green and Tiffany Payne Geyer Obtain Injunction Allowing Chapter 11 Debtor to Apply for Paycheck Protection Program Funds
• 5/11/2020
  Lynn Garson a Speaker on Podcast Focused on Attorney Mental Health
• 5/5/2020
  Daniel Pepper Speaking about Third-Party Risky During Pandemic
• 4/29/2020
  Patrick Campbell, George Stamboulidis Join Webinar on Borrowers' Regulatory Risks
• 4/29/2020
  Lee Rosebush Comments on FDA Approval for Compounding Outsourcing Facilities to Publish Shortage Drugs They Produce
• 4/27/2020
  Matthew Caligur Comments on Litigation Risk for Businesses that Reopen
• 4/23/2020
  Ann O'Brien Discusses Ways for Companies to Avoid Price-Gouging Investigations
• 4/23/2020
  Amy Traub Comments on Back-To-Work Policies as Restrictions Ease
• 4/22/2020
  Ann Caresani Comments on Back-to-Work Policies as Restrictions Ease
• 4/22/2020
  Charlene McGinty Talks to Law360 about Working in the COVID-19 Era
• 4/20/2020
  Sonny Carpenter, Ariana Dindiyal, Saima Sheikh, Catrina Wang Present Webinar on COVID-19 Workforce Issues
• 4/20/2020
  Michael Semes Article Focuses on How Taxpayers, Legislators Can Address State Budget Woes
• 4/16/2020
  Nancy Inesta Talks about the Myriad Employment Issues Caused by Pandemic
• 4/14/2020
  Andreas Kaltsounis Talks about Need for Cybersecurity During COVID-19 Crisis
• 4/9/2020
  Chris Carolan Speaks to Georgia Broadcasters about Emergency Loans
• 4/6/2020
  Gil Keteltas, Kyle Cutts Create Online Course on Force Majeure During Pandemic
• 4/3/2020
  Matthew Thurlow Comments on EPA Decision not to Reveal Waivers Sought During Pandemic
• 4/2/2020
  Jay Krupin, COVID-19 Employment Task Force Lauded by Hospitality Publication
• 4/1/2020
  Seth Hanft Talks to "Tax Notes" about CARES Act Options for Retirement Plan Participants
• 3/31/2020
  Alan Friel Supports Calls for Delay in Enforcement of CCPA
• 3/22/2020
  Ed Beckwith Talks to NBC News about Advance Directives in Wake of Coronavirus Fears
• 3/18/2020
  Amy Traub Talks about How Lawyers are Supporting Business during Coronavirus Crisis
• 3/13/2020
  Nancy Inesta Talks to "Wall Street Journal" about How Much Employers Can Ask Workers about Their Health
• 3/13/2020
  Lynn Sessions Talks about Security of Work-from-Home Arrangements
• 3/12/2020
  Lynn Sessions Discusses Privacy Issues Faced by Employers in Battling Coronavirus
• 3/6/2020
  Nathan Schacht Talks to Law360 about Coronavirus Scenarios Facing Employers
• 3/3/2020
  Nancy Inesta Talks about What Employers Can Do about Coronavirus Threat

Publications

Alerts

• 7/13/2020
  COVID-19 Update for Schools and Students
• 7/8/2020
  New York Governor Temporarily Adjusts Notary Law to Permit Use of 'Audio-Video Technology'
• 7/8/2020
  Fed Formalizes Main Street Lending Program
• 6/26/2020
  Algorithms and Intentional Discrimination or Implicit Bias? Balancing the Risks and Benefits of Facial Recognition and Artificial Intelligence During the COVID-19 Pandemic and Civil Unrest
• 6/26/2020
  SEC's Office of the Chief Accountant Issues a Statement on Continued Importance of Financial Reporting in COVID-19 Environment
• 6/26/2020
  SEC Provides Additional Guidance Regarding COVID-19 Disclosures
• 6/25/2020
  FAQs: COVID-19 – Employee Benefits Updates
• 6/18/2020
  Companies Entering the Disinfectant and Sanitizer Markets Should Proceed With Caution
• 6/16/2020
  Unpacking Antitrust Issues in the Food Industry During the Pandemic
• 6/11/2020
  Business as Usual? Considerations for Employers Before Returning Employees to the Office
• 6/10/2020
  FDA and State Boards of Pharmacy React to COVID-19 – June 10 Update
• 6/8/2020
  New York City Bars Enforcement of Personal Guaranties in Commercial Leases of COVID-19-Impacted Tenants
• 6/4/2020
  President to Sign Paycheck Protection Program Flexibility Act
• 5/18/2020
  Treasury Issues Paycheck Protection Application Regarding Forgiveness
• 5/15/2020
  Are Statutory Safe Harbors on the Horizon for Businesses and Schools Returning From COVID-19?
• 5/15/2020
  SEC Reportedly Inquiring Into Small Business Association Loan Disclosures
• 5/15/2020
  Will the SEC's Record Whistleblower Awards and COVID-19 Lead to More Whistleblower Complaints?
• 5/15/2020
  Cybercriminals' New Target: COVID-19 Treatments and Vaccines
• 5/11/2020
  Lessons Learned: Fraud and Government Enforcement in Times of Crisis
• 5/11/2020
  FDA and State Boards of Pharmacy React to COVID-19 – May 11, 2020 Update
• 5/8/2020
  California Governor Issues Executive Order Creating Rebuttable Presumption of Entitlement to Workers' Compensation Benefits for Employees Who Must Work Away from Home and Contract COVID-19
• 5/8/2020
  Important COVID-19 Deadline Extensions for Participants and Beneficiaries, and Limited Relief for Employee Benefit Plans
• 5/8/2020
  IRS Clarifies Availability of Employee Retention Tax Credit
• 5/8/2020
  First Paycheck Protection Program Fraud Charges Give Insight into Government Stimulus Investigations and Enforcement
• 5/8/2020
  From Virtual Classes to Class Actions: Higher Education Policy, Litigation and Antitrust Considerations in Responding to the COVID-19 Pandemic
• 5/8/2020
  New York Governor Extends Relief for Commercial and Residential Tenants
• 5/5/2020
  PPP Recipients Should Take Steps To Document Their Borrowings, Use of Funds and Related Transactions
• 5/5/2020
  Reopening on the Horizon? Update to Guidance on New York Governor's Executive Order No. 202.6 on the Real Estate Industry
• 5/4/2020
  No Deduction Allowed for Expenses Resulting in PPP Forgiveness
• 5/4/2020
  The SEC and Shareholders Signal Aggressive Litigation for Alleged COVID-19-Related Fraud
• 5/1/2020
  PPP and EIDL Programs Update: Small Businesses Affected by COVID-19 Pandemic Receive Substantial Additional Federal Funding and Resume Accepting Applications
• 5/1/2020
  The New Paradigm: Wealth Transfer Planning During an Economic Downturn
• 4/30/2020
  William Oxley, Meghan Kelly Article Offers Suggestions for Selecting a Jury Remotely
• 4/29/2020
  Environmental Compliance Enforcement in the Wake of COVID-19
• 4/28/2020
  Private Equity and Hedge Funds Are Out: SBA Evicts Certain Funds From the PPP Program
• 4/28/2020
  CMS Abruptly Ends Part B Advance Payments, Announces Intent to Reevaluate Part A Accelerated Payment Program
• 4/28/2020
  Summary of SBA's COVID-19 EIDL Loan Program
• 4/27/2020
  CARES Act Section 3610 Provides Federal Agencies Discretion to Reimburse Federal Contractors' Employee Compensation
• 4/27/2020
  Imports and Exports of Personnel Protective Equipment During the COVID-19 Pandemic
• 4/27/2020
  OFAC Issues Guidance on COVID-19-Related Exports and Compliance Challenges
• 4/24/2020
  SBA Gives Notice That Companies With Substantial Market Value and Access to Capital Should Pay Back PPP Loans or Not Take Them in the First Place
• 4/24/2020
  The Government's Friendly Reminder for Employers in Times of Crisis: No COVID-19 Exception to Antitrust Law Exists
• 4/24/2020
  FAQs: The Families First Coronavirus Response Act for Employers
• 4/23/2020
  DOJ COVID-19 Fraud Enforcement Actions Highlight Risks for Healthcare Companies
• 4/23/2020
  COVID-19 - States Expanding Workers' Compensation Coverage For Essential Employees
• 4/23/2020
  NYSE And Nasdaq Relaxed Listing Standards in Response to COVID-19
• 4/23/2020
  Borrower Beware: Future Government Investigations and Whistleblower Liability Based on the CARES Act Paycheck Protection Program
• 4/22/2020
  FAQs: COVID-19 – Federal and State Tax Updates
• 4/21/2020
  Adapting E-Discovery Workflows to a Remote Work Environment
• 4/20/2020
  What the Initial Wave of COVID-19 Litigation Tells Us About Future Litigation Risk
• 4/20/2020
  COVID-19's Effects on Criminal Procedure
• 4/20/2020
  Trump Allows 90-Day Deferral of Certain Import Duties in Response to COVID-19
• 4/20/2020
  FDA and State Boards of Pharmacy React to COVID-19 – April 20, 2020 Update
• 4/20/2020
  State EPA Enforcement Discretion With COVID-19
• 4/17/2020
  Product Liability and COVID-19
• 4/16/2020
  IRS Extends Deadline for Investing in Qualified Opportunity Funds for Some Taxpayers
• 4/16/2020
  CMS COVID-19 Interim Final Rule Issued With Retroactive March 1 Effective Date
• 4/16/2020
  FAQs: The Coronavirus Aid, Relief and Economic Security (CARES) Act: What It Means for Employers
• 4/16/2020
  Seven Facts Employers Need to Know About Payroll Tax Deferral
• 4/14/2020
  Relief Fund Payments Distributed to Eligible Providers: What Providers Need to Know
• 4/14/2020
  ISS Issues Policy Guidance in Response to COVID-19 Pandemic
• 4/14/2020
  Reductions-in-Force, Layoffs and Furloughs Can Trigger Unexpected PBGC Reporting and Pension Plan Funding Obligations
• 4/14/2020
  IRS Extends Some Section 1031 "Like-Kind" Exchange Deadlines
• 4/13/2020
  FDA and OHRP Issue Guidance Related to Research During the COVID-19 Pandemic
• 4/13/2020
  IRS Offers Advance Funding of Employee Retention Tax Credit
• 4/13/2020
  FAQs: The Affiliation Rules' Impact on PPP Loans to Private Equity and Venture Firms
• 4/13/2020
  FAQs: COVID-19 – General Labor and Employment Legal Concerns – April 13, 2020 Update
• 4/13/2020
  Administrative Relief: IRS Will Allow Partnerships To File Amended Returns and Real Property Businesses To Undo Interest Expense Elections
• 4/10/2020
  SEC's Chairman Clayton and Director Hinman Issue Statement on Disclosure During COVID-19
• 4/10/2020
  Update to Empire State Development's Guidance to New York Governor's Executive Order No. 202.6 as It Relates to the Real Estate Industry: What Real Estate Services Are Considered Essential Businesses?
• 4/10/2020
  FAQs: Section 139
• 4/10/2020
  Community-Based Mobile Testing Sites Will Not Be Penalized for HIPAA Violations During COVID-19 National Emergency
• 4/9/2020
  The Employee Retention Tax Credit: Aggregation Aggravation
• 4/8/2020
  SEC's Office of the Chief Accountant Issues a Statement on Financial Reporting in COVID-19 Environment
• 4/8/2020
  Los Angeles's COVID-19 Sick Leave Ordinance
• 4/8/2020
  FDA and State Boards of Pharmacy React to COVID-19 – April 8, 2020 Update
• 4/7/2020
  On the Heels of the CARES Act, Companies Should Prepare for Increased Prosecutions and Enforcement Activity
• 4/7/2020
  Empire State Development's Guidance to New York Governor's Executive Order No. 202.6 as it Relates to the Real Estate Industry: What Real Estate Services are Considered Essential Businesses?
• 4/7/2020
  COVID-19 Legislation – Healthcare Industry Impacts Deeper Dive into the CARES Act
• 4/7/2020
  COVID-19 Crisis Raises Enforcement and Litigation Risks for Disclosures by Public Issuers
• 4/6/2020
  COVID19 Update: Anti-Hoarding Enforcement
• 4/6/2020
  COVID-19 and the Emergency Exception to the Duty to Bargain
• 4/6/2020
  COVID-19 Eviction Moratoria: New Rules Affecting Landlords and Tenants
• 4/6/2020
  Georgia Gov. Brian Kemp Issues Statewide Stay-at-Home Order Affecting Individuals and Businesses
• 4/6/2020
  FAQs: COVID-19 – General Labor and Employment Legal Concerns – April 6, 2020 Update
• 4/3/2020
  Due to the COVID-19 Pandemic, HHS Eases Restrictions on the Use and Disclosure of PHI by Business Associates
• 4/3/2020
  Ohio's Governor Issues Executive Order Requesting Forbearance by Lenders, Landlords
• 4/3/2020
  Coronavirus Relief Legislation Includes Incentives for Charitable Giving
• 4/2/2020
  Understanding the Landlord, Condominium Association and Property Manager Duties During the COVID-19 Crisis
• 4/2/2020
  CMS Continues to Create Additional Regulatory Flexibilities in Efforts to Reduce Provider Burden and Focus on Patient Care
• 4/2/2020
  Commercial Real Estate Closings in the COVID-19 Climate: Practical Considerations
• 4/2/2020
  Small-to-Mid-Cap Businesses Impacted by COVID-19 Could See Change in SEC Filer Status
• 4/2/2020
  Does a Governmental Order Requiring that Businesses Close to Prevent the Further Spread of COVID-19 Amount to a Regulatory Taking of Property that Entitles a Commercial Tenant to Relief?
• 4/1/2020
  CMS Issues Stark Law Waivers for COVID-19 Purposes
• 4/1/2020
  CARES Act Significantly Revises Part 2 Rules to Better Align with HIPAA
• 4/1/2020
  Philadelphia Extends Filing, Tax Payment and Estimated Payment Due Dates and Loosens City Wage Tax Withholding Policy
• 4/1/2020
  FAQs for Small-Business Healthcare Providers about the Paycheck Protection Program
• 4/1/2020
  FDA and State Boards of Pharmacy React to COVID-19 – April 1, 2020 Update
• 4/1/2020
  FAQs: The Potential Risk of Audits and Enforcement of Misconduct Related to the Loans and Other Financial Benefits Programs Available Under the CARES Act
• 4/1/2020
  CARES Act Authorizes Funding for Midsize Lending Program
• 3/31/2020
  FAQs: CMS Expands Accelerated and Advance Payments Program in Response to COVID-19
• 3/31/2020
  Energy Contracts: In-House Counsel, Force Majeure, and the COVID-19 Pandemic
• 3/30/2020
  SEC Provides Guidance Regarding COVID-19 Disclosures
• 3/30/2020
  Recently Issued Insurance Guidance Will Impact Ohio Employment-Based Health Plans
• 3/30/2020
  Temporary U.S. EPA Enforcement Discretion in Response to COVID-19
• 3/30/2020
  FAQs: COVID-19 – General Labor and Employment Legal Concerns – March 30, 2020 Update
• 3/27/2020
  Implications Of The Coronavirus Aid, Relief, and Economic Security (CARES) Act – Healthcare Providers
• 3/27/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 27, 2020 Update
• 3/27/2020
  Ohio COVID-19 Tax Relief Legislation
• 3/27/2020
  Ohio Extending Income Tax Filing and Payment Deadline
• 3/27/2020
  President Signs $2 Trillion CARES Act With Significant Tax and Workforce Relief for Businesses and Individuals
• 3/27/2020
  SEC Watching for Bad Actors and Preserving Market Integrity During Challenging Times Caused By COVID-19
• 3/27/2020
  SEC Offers Expanded Filing Extensions to Public Companies Grappling With the Effects of COVID-19
• 3/26/2020
  Superintendent's Response to New York Governor's Executive Order 202.9 – New Part 119 to 3NYCRR
• 3/26/2020
  COVID-19 – Commercial Leases: What Landlords and Tenants Should Know
• 3/26/2020
  NMTC Considerations in Respect of COVID-19 Crisis
• 3/26/2020
  Take Note of Cuomo's Suspension of Statute of Limitations
• 3/26/2020
  CARES Act to Provide Significant Employee Benefit Plan Relief for Participants and Plan Sponsors
• 3/26/2020
  Federal Government Assumes Small Business Losses Through Forgivable Paycheck Protection Program Loans
• 3/26/2020
  Individual Income Tax Implications of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
• 3/25/2020
  Immunity From Liability for Persons Engaged in Medical Countermeasures Against the COVID-19 Pandemic
• 3/25/2020
  Debt Finance COVID-19: (1) Update on Fully Drawing Down Revolving Lines of Credit and (2) Considering Federal Payroll Loans and Other Relief? Now is the Time to Talk to Your Lender
• 3/25/2020
  Denver and Colorado: Staying at Home in the Mile High City
• 3/25/2020
  State of Georgia's Multipronged Response to COVID-19 Continues to Evolve
• 3/25/2020
  A Primer on the Effects and Implications of New York Governor's Executive Order No. 202.9: Necessary Relief for Businesses and Consumers – Challenges and Uncertainty for Licensed or Regulated Entities
• 3/25/2020
  COVID-19 and U.S. Statutes of Limitation
• 3/24/2020
  CISA, Essential Critical Infrastructure Workers and Federal Contractors
• 3/24/2020
  Top Considerations for Essential Ohio Businesses to Sustain Operations Amid COVID-19
• 3/24/2020
  FAQs: COVID-19 - State Net Operating Loss (NOL)
• 3/24/2020
  CMS Announces COVID-19 Exceptions and Extensions for Medicare Quality Reporting Programs
• 3/24/2020
  FDA Emergency Use Authorizations (EUAs): Cutting Regulatory Red Tape for COVID-19
• 3/23/2020
  Georgia Department of Labor Sets New Requirements for Mandatory Filing by Employers for Partial UI Claims
• 3/23/2020
  COVID-19 – Commercial Contracts: Risk Allocation in Times of Uncertainty
• 3/23/2020
  FAQs: COVID-19 – Considerations in M&A Transactions
• 3/23/2020
  Security Considerations for Working Remotely
• 3/23/2020
  Incentive Compensation Considerations During the COVID-19 Pandemic
• 3/23/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 23, 2020 Update
• 3/23/2020
  FAQs: Families First Coronavirus Response Act Provides Tax Credits in Limited Circumstances for Paid Sick and Family Leave
• 3/23/2020
  USTR Considers Removal of Tariffs on Certain Chinese Imports Needed for COVID-19 Response
• 3/23/2020
  Ohio Department of Health: Business Must Cease Unless Essential. Good News, Your Business May Very Well Be Essential
• 3/23/2020
  HTCs Not Immune to COVID-19
• 3/23/2020
  The COVID-19 Pandemic Raises the Importance of Understanding Whether and When Documents May Be Signed Electronically and Witnessed or Notarized Remotely
• 3/22/2020
  Testing Healthcare Workers for COVID-19: Issues and Challenges
• 3/21/2020
  CMS Approves Second Request for 1135 Medicaid Waiver
• 3/21/2020
  SEC and NFA Provide Relief and Guidance to Investment Advisers Impacted by COVID-19
• 3/21/2020
  With States Beginning to Issue ‘Stay at Home' Orders, Focus Turns to ‘Essential' Businesses That Can Remain Open
• 3/20/2020
  Virtual Stockholder Meetings in Light of Coronavirus
• 3/20/2020
  Key COVID-19 Considerations for U.S. Discovery and Information Governance
• 3/20/2020
  FAQs: COVID-19 - Hospitals and Medical Staffs
• 3/19/2020
  Impact of the President's Invocation of the Defense Production Act on Federal Contractors
• 3/19/2020
  President Trump Signs the Families First Coronavirus Response Act into Law
• 3/19/2020
  Your Business Health Checkup: How Asset Managers Are Thriving Through COVID-19
• 3/19/2020
  California Governor Issues Important Executive Order Relaxing CA WARN Requirements During COVID-19 State of Emergency
• 3/19/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 19, 2020 Update
• 3/19/2020
  FAQs: COVID-19 – Potential Impacts to Borrowers and Lenders
• 3/19/2020
  Navigating Antitrust Issues in the Wake of COVID-19
• 3/19/2020
  CMS Issues Guidance to Protect Nursing Home Residents From COVID-19
• 3/19/2020
  COVID19 Update: AG Barr Issues Memo Focusing Enforcement on Corona Related Fraud and Crime
• 3/19/2020
  COVID-19: Board Oversight and Crisis Management
• 3/19/2020
  COVID-19: Public and Private Disclosures and Other Securities Issues
• 3/18/2020
  FAQs: COVID-19 - Labor and Employment Legal Concerns
• 3/18/2020
  FAQs: COVID-19 - Force Majeure and Other Defenses to Contractual Performance
• 3/18/2020
  HHS Issues Two Important Bulletins Waiving HIPAA Sanctions During the COVID-19 National Emergency
• 3/18/2020
  Telehealth Toolkit: CMS Gives Providers Nationwide Flexibility to ‘See' Patients
• 3/18/2020
  Coronavirus (COVID-19) Government Contracts Advisory
• 3/17/2020
  FDA and State Boards of Pharmacy React to Coronavirus – Update
• 3/17/2020
  Have you Thought About ... How the COVID-19 Pandemic Impacts Your State and Local Tax Posture Now that Employees are Conducting More Activities from Remote Locations?
• 3/17/2020
  CMS Approves First Emergency Medicaid Waiver Request to Accelerate Access to Services in Response to COVID-19
• 3/16/2020
  What Employers Should Know About the Families First Coronavirus Response Act
• 3/16/2020
  FDA and State Boards of Pharmacy React to Coronavirus
• 3/2/2020
  BakerHostetler Develops COVID-19 Employment Issues Task Force (CEIT) to Address Workplace Concerns
• 2/28/2020
  COVID–19 and the Law: Fighting the Fear with the Facts

Articles

• 6/22/2020
  Ann O'Brien, Brady Cummins Co-Write Price-Gouging Article for ABA's The Antitrust Source
• 6/9/2020
  Amy Traub Co-Authors Analysis of Employer Strategies to Limit COVID-19 Discrimination Claims
• 5/15/2020
  Keith Durkin Authors Articles Examining IRS Code §199A, SECURE Act
• 5/11/2020
  Dan Buzzetta Authors Article on New York's Usury Laws
• 5/6/2020
  John Carney, Bari Nadworny Article Discusses Disclosures During COVID-19 Crisis
• 4/27/2020
  Carl Hittinger, Brady Cummins Article Examines Competitor Collaborations During Pandemic
• 4/22/2020
  John Carney, Lee Rosebush, Susrut Carpenter, Andrew Serrao Author Write about FDA Pharma Facility Inspections Amid Pandemic
• 4/16/2020
  Carl Hittinger, Ann O'Brien Article Examines Antitrust Risk During COVID-19 Crisis
• 3/30/2020
  Gilbert Brosky Authors Article Outlining Deterrents to Pandemic-Related Work Class Action Claims
• Keith Durkin Article Examines Revised Term Sheets for Main Street Lending Program

Videos

• 6/23/2020
  The Failing Firm Antitrust Defense – How To Navigate Financially Troubled Mergers During a Pandemic
• 6/11/2020
  Washington's Response to COVID-19: Majority Leader Steny Hoyer, D-Md.
• 6/10/2020
  Washington's Response to COVID-19: Congressman Patrick McHenry, R-N.C.
• 6/3/2020
  Washington's Response to COVID-19: Republican Whip Steve Scalise, R-La.
• 6/2/2020
  Equity Markets and the COVID-19 Pandemic
• 6/1/2020
  Washington's Response to COVID-19: Majority Whip James E. Clyburn, D-S.C.
• 5/27/2020
  Leveraging Business Model Uncertainty to Drive Digital Transformation and Smart Data Strategies
• 5/20/2020
  Accelerate: Getting to Your North Star Faster
• 5/20/2020
  Washington's Response to COVID-19: Senator Cory Booker, D-N.J.
• 5/19/2020
  Washington's Response to COVID-19: Senator John Barrasso, R-Wyo.
• 5/13/2020
  Washington's Response to COVID-19: Congressman Hakeem Jeffries, D-N.Y.
• 5/6/2020
  Positioning for What's Beyond the Horizon: What Digital Transformation and The Data Economy Mean for You
• 4/29/2020
  Fraud and Government Enforcement in Times of Crisis
• 4/23/2020
  Marketing, Promoting and Pricing Your Products During the Pandemic
• 4/21/2020
  Washington's Response to COVID-19: Congressman Michael C. Burgess, M.D., R-Texas
• 4/15/2020
  Fed-Backed Credit Facilities From the CARES Act: Implications for Businesses
• 4/14/2020
  Corporate Disclosure and Enforcement Impact of COVID-19 on SEC Filings
• 4/13/2020
  COVID-19 Pandemic: Antitrust Risks and Possible Protection Under the Defense Production Act and State Action Immunity Doctrine
• 4/6/2020
  Washington's Response to COVID-19: Congresswoman Stephanie Murphy, D-Fla.
• 4/2/2020
  Washington's Response to COVID-19: Senator Roy Blunt, R-Mo.
• 3/31/2020
  $2 Trillion CARES Act Provides Significant Tax and Workforce Relief for Businesses, Individuals

Blog Posts

• 6/24/2020
  CPRA Moves Forward Despite COVID-19 Woes
• 6/18/2020
  USPTO Grants Relief for Patent Applicants Who Failed to Timely File Patent Applications Due to the COVID-19 Outbreak
• 6/16/2020
  Fast-Track Examination for COVID-19-Related Trademarks and Service Marks
• 6/15/2020
  The Potential Patent Risks Associated with COVID-19 Collaborations
• 6/3/2020
  AB 2457: A Potential Helping Hand for California Employers in a Time of Need
• 6/2/2020
  Accelerate: Getting to Your North Star Faster
• 5/28/2020
  USPTO Further Extends Certain Patent Due Dates Only for Small and Micro Entities
• 5/21/2020
  Key COVID-19 Considerations for U.S. Discovery and Information Governance
• 5/21/2020
  Adapting E-Discovery Workflows to a Remote Work Environment
• 5/21/2020
  COVID-19 and U.S. Statutes of Limitation
• 5/20/2020
  The Failing Firm Defense in Times of Economic Uncertainty
• 5/18/2020
  Can a Good Deed Ever Go Unpunished? Patent Infringement Considerations for Technologies Used to Combat COVID-19
• 5/15/2020
  Industry Initiatives to Ensure Access to Intellectual Property Rights Associated With COVID-19 Treatment
• 5/13/2020
  Key UPSTO Initiatives to Ease Burden On Patent Owners and Patent Applicants During the COVID-19 Outbreak
• 5/12/2020
  A Brief Summary of the Key USPTO Initiatives to Speed Up Development of Treatment for COVID-19
• 5/11/2020
  Privacy Litigation in the Age of Coronavirus
• 5/8/2020
  Positioning for What's Beyond the Horizon: What Digital Transformation and the Data Economy Mean for You
• 4/28/2020
  COVID-19 and the DPA: First Criminal Complaint Filed by the Justice Department in New York
• 4/23/2020
  Joint Agencies Issue Guidance on Prevalence of Cyberattacks Exploiting COVID-19 and Teleworking
• 4/22/2020
  Takedown Tips for Brands Battling Unauthorized Distribution During the COVID-19 Pandemic
• 4/21/2020
  3M Joins the Fight Against Rampant Price Gouging
• 4/20/2020
  New Jersey's Expansion of Family Leave for COVID-19
• 4/13/2020
  Federal Circuit's COVID-19 Response Brings Public Telephonic Oral Arguments and Patent Cases Decided on the Briefs
• 4/13/2020
  Considerations for 3D Printing of Medical Devices, Accessories, Components and Parts During the COVID-19 Pandemic
• 4/10/2020
  US Patent and Trademark Office Issues FAQ on Temporary Extension of Due Date in Patent and Trademark Matters Authorized by CARES Act
• 4/10/2020
  COVID-19: Pricing During COVID-19 Without Gouging or Fixing
• 4/9/2020
  New York Passes Statewide Paid Sick Leave Law
• 4/9/2020
  Focus on Children's Privacy Intensifies as Daily Life Moves Online
• 4/8/2020
  COVID-19 Update: Pricing During COVID-19 Without Gouging or Fixing
• 4/7/2020
  Combating COVID-19 Through Competitor Collaboration
• 4/3/2020
  Due to the COVID-19 Pandemic, HHS Eases Restrictions on the Use and Disclosure of PHI by Business Associates
• 4/2/2020
  COVID-19 Antitrust Agency Procedural Changes
• 4/2/2020
  3D Printing Comes of Age in the COVID-19 Crisis
• 4/1/2020
  US Patent and Trademark Office Uses Authority Granted Under CARES Act to Temporarily Extend Due Date for Certain Patent and Trademark Matters
• 4/1/2020
  Healthcare Providers Remain Targets for Ransomware Attacks in the Midst of COVID-19 Pandemic
• 3/30/2020
  COVID-19 Update: FTC and States Combat Scams, Price Gouging and Deceptive Ads
• 3/27/2020
  Patent Portfolio Considerations During Times of Financial Uncertainty
• 3/27/2020
  The Coronavirus Aid, Relief, and Economic Security Act Grants the US Patent and Trademark Office the Authority to Manage Statutory Due Dates
• 3/26/2020
  Really? Someone thinks I HEART COVID-19 should be awarded a US trademark registration?
• 3/25/2020
  Executive Order Addresses DOJ's Fight Against Hoarding Activity
• 3/23/2020
  Dealing With COVID-19 in Your Workplace Without Inviting Future Class Actions
• 3/23/2020
  Protection of Consumers and the Public in Response to the COVID-19 Pandemic
• 3/19/2020
  CORONAVIRUS UPDATE: $1 Trillion Stimulus Next Up
• 3/19/2020
  New York State Passes Statewide Paid Sick Leave Related to COVID-19
• 3/19/2020
  COVID-19 Update: Congress' Risk to Public Companies
• 3/18/2020
  Additional 6-Month CCPA Extension Sought in Wake of COVID-19
• 3/18/2020
  HHS Issues Two Important Bulletins Waiving HIPAA Sanctions During the COVID-19 National Emergency
• 3/18/2020
  COVID-19 Cybersecurity Exposure
• 3/17/2020
  USPTO Waives Petition to Revive Fees for Patents, Patent Applications, Trademarks and Trademark Applications Abandoned Because of an Inability to Respond Due to COVID-19
• 3/16/2020
  FERPA Disclosures in Response to COVID-19
• 3/11/2020
  COVID-19 Update: Consumer Class Action Filed Over Hand Sanitizer Claims
• 3/9/2020
  Regulators Issue Warning: These Products Cannot Treat Coronavirus

Events

• 6/23/2020
  Webinar: The Failing Firm Antitrust Defense – How To Navigate Financially Troubled Mergers During a Pandemic
• 6/11/2020
  Webinar: Washington's Response to COVID-19: Majority Leader Steny Hoyer, D-Md.
• 6/10/2020
  Webina: Washington's Response to COVID-19: Congressman Patrick McHenry, R-N.C.
• 6/10/2020
  Webinar: Recalling, Rehiring, and Hiring Anew: Proactive COVID-19 Strategies to Limit Systemic Discrimination Risk
• 6/3/2020
  Webinar Series: Washington's Response to COVID-19: Republican Whip Steve Scalise, R-La.
• 6/1/2020
  Webinar Series: Washington's Response to COVID-19: Majority Whip James E. Clyburn, D-S.C.
• 5/20/2020
  Webinar Series: Washington's Response to COVID-19: Senator Cory Booker, D-N.J.
• 5/19/2020
  Webinar Series: Washington's Response to COVID-19: Senator John Barrasso, R-Wyo.
• 5/13/2020
  Webinar Series: Washington's Response to COVID-19: Congressman Hakeem Jeffries, D-N.Y.
• 5/6/2020
  Webinar Series: Washington's Response to COVID-19: Senator Ted Cruz, R-Texas
• 5/6/2020
  Digital Transformation and Data Economy Four-Part Webinar Series
• 4/29/2020
  Webinar: Fraud and Government Enforcement in Times of Crisis
• 4/23/2020
  CLE Webinar: Marketing, Promoting and Pricing Your Products During the Pandemic
• 4/21/2020
  Webinar Series: Washington's Response to COVID-19: Congressman Michael C. Burgess, M.D., R-Texas
• 4/16/2020
  Webinar Series: Washington's Response to COVID-19: Senator Chris Van Hollen, D-Md.
• 4/15/2020
  Webinar: Fed-Backed Credit Facilities From the CARES Act: Implications for Businesses
• 4/14/2020
  Webinar Series: Washington's Response to COVID-19: Senator Thom Tillis, R-N.C.
• 4/14/2020
  Webinar: Corporate Disclosure and Enforcement Impact of COVID-19 on SEC Filings
• 4/13/2020
  Webinar: COVID-19 Pandemic: Antitrust Risks and Possible Protection Under the Defense Production Act and State Action Immunity Doctrine
• 4/9/2020
  Webinar Series: Washington's Response to COVID-19: Congressman Josh Gottheimer, D-N.J.
• 4/6/2020
  Webinar Series: Washington's Response to COVID-19: Congresswoman Stephanie Murphy, D-Fla.
• 4/2/2020
  Webinar Series: Washington's Response to COVID-19: Senator Roy Blunt, R-Mo.
• 3/31/2020
  Webinar: $2 Trillion CARES Act Provides Significant Tax and Workforce Relief for Businesses, Individuals
• 3/26/2020
  Managing COVID-19 Webinar Series: Part 3 - A Primer for Health Care Providers, Life Sciences Companies, and Insurers
• 3/25/2020
  Managing COVID-19 Webinar Series: Part 2 - Navigating Challenges in Corporate Governance & Transactions
• 3/24/2020
  Managing COVID-19 Webinar Series: Part 1 - Managing Business Continuity Impacts to the Workforce and Workplace
• 3/24/2020
  Managing COVID-19 Webinar Series: Critical Legal Issues For U.S. Businesses & Their Counsel